BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35724624)

  • 1. Factors associated with enrolment in clinical trials among women with early-stage breast cancer.
    Presti D; Havas J; Soldato D; Lapidari P; Martin E; Pistilli B; Jouannaud C; Emile G; Rigal O; Fournier M; Soulie P; Mouret-Reynier MA; Tarpin C; Campone M; Guillermet S; Martin AL; Everhard S; Di Meglio A
    ESMO Open; 2022 Jun; 7(3):100513. PubMed ID: 35724624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-Related Amenorrhea and Quality of Life Among Premenopausal Women With Breast Cancer.
    Kabirian R; Franzoi MA; Havas J; Coutant C; Tredan O; Levy C; Cottu P; Dhaini Mérimèche A; Guillermet S; Ferrero JM; Giacchetti S; Petit T; Dalenc F; Rouanet P; Everhard S; Martin AL; Pistilli B; Lambertini M; Vaz-Luis I; Di Meglio A
    JAMA Netw Open; 2023 Nov; 6(11):e2343910. PubMed ID: 37971739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home-based multidimensional survivorship programmes for breast cancer survivors.
    Cheng KKF; Lim YTE; Koh ZM; Tam WWS
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.
    Ferreira AR; Di Meglio A; Pistilli B; Gbenou AS; El-Mouhebb M; Dauchy S; Charles C; Joly F; Everhard S; Lambertini M; Coutant C; Cottu P; Lerebours F; Petit T; Dalenc F; Rouanet P; Arnaud A; Martin A; Berille J; Ganz PA; Partridge AH; Delaloge S; Michiels S; Andre F; Vaz-Luis I
    Ann Oncol; 2019 Nov; 30(11):1784-1795. PubMed ID: 31591636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial.
    Kawashima Y; Fukuhara T; Saito H; Furuya N; Watanabe K; Sugawara S; Iwasawa S; Tsunezuka Y; Yamaguchi O; Okada M; Yoshimori K; Nakachi I; Seike M; Azuma K; Kurimoto F; Tsubata Y; Fujita Y; Nagashima H; Asai G; Watanabe S; Miyazaki M; Hagiwara K; Nukiwa T; Morita S; Kobayashi K; Maemondo M
    Lancet Respir Med; 2022 Jan; 10(1):72-82. PubMed ID: 34454653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial.
    Galle PR; Finn RS; Qin S; Ikeda M; Zhu AX; Kim TY; Kudo M; Breder V; Merle P; Kaseb A; Li D; Mulla S; Verret W; Xu DZ; Hernandez S; Ding B; Liu J; Huang C; Lim HY; Cheng AL; Ducreux M
    Lancet Oncol; 2021 Jul; 22(7):991-1001. PubMed ID: 34051880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry.
    Husson O; de Rooij BH; Kieffer J; Oerlemans S; Mols F; Aaronson NK; van der Graaf WTA; van de Poll-Franse LV
    Oncologist; 2020 Apr; 25(4):e722-e732. PubMed ID: 32297435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy.
    Perrone F; Jommi C; Di Maio M; Gimigliano A; Gridelli C; Pignata S; Ciardiello F; Nuzzo F; de Matteis A; Del Mastro L; Bryce J; Daniele G; Morabito A; Piccirillo MC; Rocco G; Guizzaro L; Gallo C
    Ann Oncol; 2016 Dec; 27(12):2224-2229. PubMed ID: 27789469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Predictive Model of Severe Fatigue After Breast Cancer Diagnosis: Toward a Personalized Framework in Survivorship Care.
    Di Meglio A; Havas J; Soldato D; Presti D; Martin E; Pistilli B; Menvielle G; Dumas A; Charles C; Everhard S; Martin AL; Coutant C; Tarpin C; Vanlemmens L; Levy C; Rigal O; Delaloge S; Lin NU; Ganz PA; Partridge AH; André F; Michiels S; Vaz-Luis I
    J Clin Oncol; 2022 Apr; 40(10):1111-1123. PubMed ID: 35061509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial.
    Velikova G; Williams LJ; Willis S; Dixon JM; Loncaster J; Hatton M; Clarke J; Kunkler IH; Russell NS;
    Lancet Oncol; 2018 Nov; 19(11):1516-1529. PubMed ID: 30337220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of use of oral complementary-alternative medicine among women with early breast cancer: a focus on cancer-related fatigue.
    Lapidari P; Djehal N; Havas J; Gbenou A; Martin E; Charles C; Dauchy S; Pistilli B; Cadeau C; Bertaut A; Everhard S; Martin AL; Coutant C; Cottu P; Menvielle G; Dumas A; Andre F; Michiels S; Vaz-Luis I; Di Meglio A
    Breast Cancer Res Treat; 2021 Dec; 190(3):517-529. PubMed ID: 34559354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of Life of Women After a First Diagnosis of Breast Cancer Using a Self-Management Support mHealth App in Taiwan: Randomized Controlled Trial.
    Hou IC; Lin HY; Shen SH; Chang KJ; Tai HC; Tsai AJ; Dykes PC
    JMIR Mhealth Uhealth; 2020 Mar; 8(3):e17084. PubMed ID: 32130181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of radiation therapy on fatigue at 1 year in breast cancer survivors in the prospective multicentre CANcer TOxicity cohort.
    Ghannam Y; Di Meglio A; Sarrade T; Jacquet A; Everhard S; Kirova Y; Peignaux K; Guilbert P; Charra-Brunaud C; Blanchecotte J; Bochaton OF; Pasquier D; Racadot S; Bourgier C; Geffrelot J; Benyoucef A; Paris F; Auzac G; Luis IV; Rivera S
    Eur J Cancer; 2022 Dec; 177():143-153. PubMed ID: 36356418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
    Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
    Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bridging the Age Gap in breast cancer: Impact of chemotherapy on quality of life in older women with early breast cancer.
    Battisti NML; Reed MWR; Herbert E; Morgan JL; Collins KA; Ward SE; Holmes GR; Bradburn M; Walters SJ; Burton M; Lifford K; Edwards A; Robinson TG; Martin C; Chater T; Pemberton KJ; Shrestha A; Brennan A; Cheung KL; Todd A; Audisio RA; Wright J; Simcock R; Green T; Revell D; Gath J; Horgan K; Holcombe C; Winter MC; Naik J; Parmeshwar R; Gosney MA; Hatton MQ; Thompson AM; Wyld L; Ring A;
    Eur J Cancer; 2021 Feb; 144():269-280. PubMed ID: 33373871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of Long-Term Patient-Reported Quality of Life and Health Behaviors After Adjuvant Breast Cancer Chemotherapy.
    Di Meglio A; Havas J; Gbenou AS; Martin E; El-Mouhebb M; Pistilli B; Menvielle G; Dumas A; Everhard S; Martin AL; Cottu PH; Lerebours F; Coutant C; Lesur A; Tredan O; Soulie P; Vanlemmens L; Joly F; Delaloge S; Ganz PA; André F; Partridge AH; Jones LW; Michiels S; Vaz-Luis I
    J Clin Oncol; 2022 Sep; 40(27):3190-3204. PubMed ID: 35446677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.
    Piccart M; van 't Veer LJ; Poncet C; Lopes Cardozo JMN; Delaloge S; Pierga JY; Vuylsteke P; Brain E; Vrijaldenhoven S; Neijenhuis PA; Causeret S; Smilde TJ; Viale G; Glas AM; Delorenzi M; Sotiriou C; Rubio IT; Kümmel S; Zoppoli G; Thompson AM; Matos E; Zaman K; Hilbers F; Fumagalli D; Ravdin P; Knox S; Tryfonidis K; Peric A; Meulemans B; Bogaerts J; Cardoso F; Rutgers EJT
    Lancet Oncol; 2021 Apr; 22(4):476-488. PubMed ID: 33721561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of high adherence to vegetables and fruits dietary pattern with quality of life among Chinese women with early-stage breast cancer.
    Lei YY; Ho SC; Kwok C; Cheng A; Cheung KL; Lee R; Mo FKF; Yeo W
    Qual Life Res; 2022 May; 31(5):1371-1384. PubMed ID: 34532834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.